Eli Lefler
Impact in
- Microbiology top 10%
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
- Epidemiology 10
- Fungal Infections and Studies 7
- Nail Diseases and Treatments 3
-
- Antifungal resistance and susceptibility 9
- Co-authors
- Uri Rehany (3 shared papers)Shimon Rumelt (2 shared papers)D. A. Stevens (1 shared paper)David A. Stevens (4 shared papers)D. Merzbach (5 shared papers)A Bickel (1 shared paper)A. Eitan (1 shared paper)Dietmar Urbach (1 shared paper)
- Journals
- Mycoses (3 papers)Cornea (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Ophthalmology (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Eli Lefler
21 papers receiving 309 citations
Peers
Comparison fields: 5 of 63
- Microbiology 10
- Infectious Diseases 115
- Ophthalmology 51
- Endocrinology 20
- Small Animals 25
Countries citing papers authored by Eli Lefler
This map shows the geographic impact of Eli Lefler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Lefler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lefler more than expected).
Fields of papers citing papers by Eli Lefler
This network shows the impact of papers produced by Eli Lefler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Lefler. The network helps show where Eli Lefler may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Lefler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 66 | |
| 2 | 1998 | 42 | |
| 3 | 1984 | 38 | |
| 4 | 2001 | 27 | |
| 5 | 1981 | 22 | |
| 6 | 1989 | 17 | |
| 7 | 2004 | 16 | |
| 8 | 1987 | 14 | |
| 9 | 1998 | 11 | |
| 10 | 1985 | 10 | |
| 11 | 1992 | 10 | |
| 12 | 2001 | 9 | |
| 13 | 1985 | 8 | |
| 14 | 1985 | 8 | |
| 15 | 1979 | 7 | |
| 16 | 1994 | 6 | |
| 17 | 1992 | 6 | |
| 18 | 1986 | 5 | |
| 19 | Occurrence of Demodex in nose follicles of outpatients attending an otorhinolaryngology clinic. | 1989 | 3 |
| 20 | Phaeohyphomycosis followed by paecilomycosis of nose septum in a neutropenic patient. | 1990 | 2 |
About Eli Lefler
Eli Lefler is a scholar working on Epidemiology, Infectious Diseases, Small Animals, Cell Biology and Dermatology, having authored 21 papers that have together received 328 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (7 papers), Infectious Diseases and Mycology (4 papers), Plant Pathogens and Fungal Diseases (3 papers), Nail Diseases and Treatments (3 papers), Streptococcal Infections and Treatments (1 paper), Sinusitis and nasal conditions (1 paper) and Vibrio bacteria research studies (1 paper). The work is most often cited by research in Microbiology (10 citations), Infectious Diseases (115 citations), Ophthalmology (51 citations), Endocrinology (20 citations) and Small Animals (25 citations). Eli Lefler has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Uri Rehany, Shimon Rumelt, D. A. Stevens, David A. Stevens, D. Merzbach, A Bickel, A. Eitan, Dietmar Urbach, Eddy Barasch and Pierre Singer. Their work appears in journals such as Mycoses, Cornea, Antimicrobial Agents and Chemotherapy, Ophthalmology and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.